Figure 2: Decrease in human islet function in vitro. Measurement of insulin release on days 17, 20, 24, 27, 32, 34 and day 38 (A), IL-1β release on days 8, 15, 35 and 63 (B) and Extracellular ATP levels on day 8, 35 and 63(C).